AVR
Health Care Equipment & Services
Anteris Technologies Global
- Short interest
- 1.97%
- +1.97 pp 30d
- as of 20 Aug 2026
- Reported shorts
- 298.2K
- Shares on issue
- 15.127M
Anteris Technologies Global (AVR) company profile
Profile, insiders and operations
Company
AI-generated research profile of Anteris Technologies Global
heart valves
medical devices
biotechnology
healthcare innovation
ASX-listed
Anteris Technologies Ltd specializes in developing advanced heart valve technologies, focusing on delivering innovative solutions to address unmet medical needs in cardiac surgery. Positioned as a frontrunner in the heart valve market, Anteris leverages its proprietary ADAPT tissue technology and DurAVR 3D single-piece aortic heart valves to enhance patient outcomes. The company's unique value lies in its commitment to revolutionizing cardiovascular care with cutting-edge scientific research and development.
Director trades
18 trades recorded
AVR intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Sign in to unlock the dossierFree account · no card required